Compare CFFI & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CFFI | ACB |
|---|---|---|
| Founded | 1927 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.4M | 250.1M |
| IPO Year | 1996 | 2016 |
| Metric | CFFI | ACB |
|---|---|---|
| Price | $74.89 | $3.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.0K | ★ 965.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | ★ 37.94 | N/A |
| EPS | ★ 8.29 | N/A |
| Revenue | ★ $140,841,000.00 | N/A |
| Revenue This Year | N/A | $6.89 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.84 | ★ N/A |
| Revenue Growth | ★ 10.63 | N/A |
| 52 Week Low | $53.14 | $3.28 |
| 52 Week High | $80.99 | $6.67 |
| Indicator | CFFI | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 44.94 |
| Support Level | $66.92 | $3.28 |
| Resistance Level | $80.01 | $3.91 |
| Average True Range (ATR) | 1.24 | 0.15 |
| MACD | -0.53 | 0.03 |
| Stochastic Oscillator | 34.40 | 55.19 |
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.